Skip to content
Screener

Altimmune ALT Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$15.37B-14.7%
Merck & Co. logo
Merck & Co.MRK
$10.77B+7.7%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$68.57M+17.0%
VAN
Vivani MedicalVANI
$1.1M-33.9%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1.22M+41.5%
Delcath Systems logo
Delcath SystemsDCTH
$6.98M+14.1%

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$593.15M+116%
Enterprise value$530.27M+402%

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Altimmune’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001326190-26-000040
Line itemMarch 31, 2026December 31, 2025
Short-term investments233,939229,696
Accounts and other receivables1,6651,219
Income tax and R&D incentive receivables518
Prepaid expenses and other current assets1,4292,957
Total current assets334,676278,192
Property and equipment, net208312
Other assets7461,425
Total assets$335,630$279,929

Item 1. Financial Statements

FAQ

What is Altimmune's prepaid & other current?
Altimmune (ALT) reported prepaid & other current of $1.43M in Q1 2026.
How has Altimmune's prepaid & other current changed year-over-year?
Altimmune's prepaid & other current decreased by 51.2% year-over-year, from $2.93M to $1.43M.
What is the long-term trend for Altimmune's prepaid & other current?
Over 5 years (2020 to 2025), Altimmune's prepaid & other current has grown at a 8.9% compound annual growth rate (CAGR), from $1.93M to $2.96M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Altimmune's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude